This publication shows how our « free of hypothesis » approach can describe all the effects which are induced by an ingredient on an ex vivo classic model. It gives for the ingredient a more extensive understanding of the mechanisms of action and some specific insights, which were also predictive as confirmed at the clinical level, and which allowed supporting a complete and original claiming.
This method shows huge advantages :
– It is based on proteins which are in charge of the structure and the metabolic functions in the cells,
– It is untargeted, which allows to have at the same time a complete view on positive and possible toxic effects.
Pubmed https://www.ncbi.nlm.nih.gov/pubmed/29797450
30620 BERNIS
Tel : +33 4 66 04 77 99
Fax : +33 4 66 04 77 97
e-mail : gskorski@phylogene.com
web : www.phylogene.com
LinkedIn : https://www.linkedin.com/company/phylogene
Twitter : https://twitter.com/Phylogene_One
In a world where life expectancy continues to increase, the concept of longevity no longer…
The Korea Institute of Dermatological Sciences has been conducting safety and efficacy evaluations, in-vitro evaluations,…
CLAIM® is an Argentina-based Contract Research Organization (CRO) specializing in the design, development, and execution…